default author photo

Giulia Pasello

affiliation not provided to SSRN

SCHOLARLY PAPERS

6

DOWNLOADS

230

TOTAL CITATIONS

0

Scholarly Papers (6)

1.

Advanced-Stage Alk-Positive Non–Small-Cell Lung Cancer (Nsclc) Patients: Real-World Treatment Patterns and Outcomes from the Italian Biomarker Atlas Database

Number of pages: 24 Posted: 15 May 2025
“Vito Fazzi” Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Turin, affiliation not provided to SSRN, Università degli Studi di Udine - Azienda Sanitaria Universitaria Integrata di Udine, affiliation not provided to SSRN, Ospedale Giovanni Paolo II, affiliation not provided to SSRN, IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" (IRST), Pederzoli Hospital-Peschiera del Garda, University of Pavia, University Hospital of Parma, University of Milano-Bicocca - Fondazione IRCCS San Gerardo dei Tintori, University of Verona, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Florence, University of Pisa, University Hospital Careggi, affiliation not provided to SSRN, Cardinal Massaia Hospital, Università Vita-Salute San Raffaele - San Raffaele Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, ASST Papa Giovanni XXIII, Università degli Studi di Genova, Regione Veneto - Azienda Ulss 3 Serenissima, affiliation not provided to SSRN, Ospedale Michele e Pietro Ferrero - Verduno, affiliation not provided to SSRN, affiliation not provided to SSRN, Azienda Ospedaliera Ospedali Riuniti Marche Nord, affiliation not provided to SSRN, affiliation not provided to SSRN, San Giovanni di Dio Hospital,, Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Gynecologic Unit, University of Naples Federico II, University of Turin, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 65 (916,100)

Abstract:

Loading...

alectinib, ALK, Non-small-cell lung cancer, ALK TKIs, Lorlatinib

2.

TREATMENT RESPONSE AFTER INDUCTION THERAPY IN ADVANCED THYMIC TUMORS: RESULTS FROM THE ITALIAN NATIONWIDE TYME DATABASE

Number of pages: 32 Posted: 24 Oct 2025
Fondazione IRCCS Istituto Nazionale dei Tumori, Fondazione IRCCS Istituto Nazionale dei Tumori, Fondazione IRCCS Istituto Nazionale dei Tumori, Fondazione IRCCS Istituto Nazionale dei Tumori, Fondazione IRCCS Istituto Nazionale dei Tumori, Fondazione IRCCS Istituto Nazionale dei Tumori, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, IRCCS Humanitas Research Hospital, University of Pisa, Pisa University - Pisa University Hospital, University of Pisa, University of Milan, University of Milan, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Naples Federico II, affiliation not provided to SSRN, Fondazione IRCCS Istituto Nazionale dei Tumori, University of Pisa, Fondazione IRCCS Istituto Nazionale dei Tumori - Department of Research, Humanitas Gavazzeni, Humanitas Gavazzeni, affiliation not provided to SSRN, Universita di Torino, affiliation not provided to SSRN, Istituto Clinico Humanitas, affiliation not provided to SSRN, affiliation not provided to SSRN and Fondazione IRCCS Istituto Nazionale dei Tumori
Downloads 43 (1,145,425)

Abstract:

Loading...

Advanced thymic tumors, induction therapy, multimodal treatment, radiological response, ECOG performance status, ASA score, surgical outcomes, recurrence-free survival, Overall Survival, TYME database, Thoracic Oncology

3.

Braf-Mutant Metastatic Non–Small-Cell Lung Cancer: Real World Data from the Italian Biomarker Atlas Database

Number of pages: 25 Posted: 12 Jun 2025
Ospedale Giovanni Paolo II, affiliation not provided to SSRN, University of Milano-Bicocca - Fondazione IRCCS San Gerardo dei Tintori, affiliation not provided to SSRN, University of Parma, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Careggi University Hospital of Florence - Clinical Oncology Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" (IRST), “Vito Fazzi” Hospital, University of Verona - Hospital Trust, Cardinal Massaia Hospital, Pederzoli Hospital-Peschiera del Garda, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Pisa, ASST Papa Giovanni XXIII, Regione Veneto - Azienda Ulss 3 Serenissima, affiliation not provided to SSRN, affiliation not provided to SSRN, San Giovanni di Dio Hospital,, affiliation not provided to SSRN, Università degli Studi di Genova, University of Florence, affiliation not provided to SSRN, University of Verona, affiliation not provided to SSRN, University of Pavia, Azienda Ospedaliera Ospedali Riuniti Marche Nord, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Ospedale Michele e Pietro Ferrero - Verduno, affiliation not provided to SSRN, Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Gynecologic Unit, University of Naples Federico II, University of Turin, University of Turin and affiliation not provided to SSRN
Downloads 39 (1,196,171)

Abstract:

Loading...

BRAF mutations, dabrafenib, trametinib, immunotherapy, BRAF V600E, NSCLC, real-world evidence.

4.

Outcome and Safety of Lurbinectedin as Compassionate Use in Extensive Stage Small Cell Lung Cancer: A Multicentric International Cohort

Number of pages: 22 Posted: 02 Jun 2025
affiliation not provided to SSRN, Erasmus University Rotterdam, Istituto Oncologico Veneto – IRCCS, affiliation not provided to SSRN, Erasmus University Rotterdam (EUR) - Department of Pulmonary Diseases, affiliation not provided to SSRN and Erasmus University Rotterdam (EUR) - Department of Pulmonary Medicine
Downloads 31 (1,304,549)

Abstract:

Loading...

small cell lung cancer, lurbinectedin, real-world, effectiveness

5.

CHIMERA: a phase II study of neoadjuvant pembrolizumab in combination with cisplatin or carboplatin and pemetrexed followed by surgery and adjuvant pembrolizumab in resectable pleural mesothelioma

Number of pages: 10 Posted: 07 Jan 2026
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Università degli Studi di Bari “Aldo Moro” (UNIBA), affiliation not provided to SSRN, Humanitas Gavazzeni, University of Parma, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Ferrara, affiliation not provided to SSRN, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - IRCCS Veneto Institute of Oncology (IOV-IRCCS), affiliation not provided to SSRN, affiliation not provided to SSRN, University of Padova - Department of Cardiac, Thoracic, Vascular Science and Public Health, affiliation not provided to SSRN, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 29 (1,332,057)

Abstract:

Loading...

Pleural Mesothelioma, Immunotherapy, perioperative, pleurectomy, multimodality

6.

The biomarkers ATLAS knowledge-based database: a two-year challenge updates for non-small cell lung cancer patients

Number of pages: 29 Posted: 28 Apr 2026
University of Naples Federico II, “Vito Fazzi” Hospital, University of Turin, University of Naples Federico II, University of Milano-Bicocca - Fondazione IRCCS San Gerardo dei Tintori, University of Padua - Department of Medicine, University of Naples Federico II, affiliation not provided to SSRN, University of Turin, affiliation not provided to SSRN, University of Milano-Bicocca, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Naples Federico II, University of Verona, University Hospital of Parma, Università degli Studi di Genova, University of Turin, affiliation not provided to SSRN, University of Florence, affiliation not provided to SSRN, Ospedale Giovanni Paolo II, affiliation not provided to SSRN, affiliation not provided to SSRN, Università Vita-Salute San Raffaele - San Raffaele Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Naples Federico II - Department of Public Health, University of Turin and University of Naples Federico II
Downloads 23 (1,411,822)

Abstract:

Loading...

database, molecular records, clinical records, NSCLC